Westwood Holdings Group Inc. Sells 36,559 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Westwood Holdings Group Inc. cut its position in shares of Avanos Medical, Inc. (NYSE:AVNS) by 1.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,114,532 shares of the company’s stock after selling 36,559 shares during the period. Westwood Holdings Group Inc. owned about 4.61% of Avanos Medical worth $42,100,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Alberta Investment Management Corp boosted its stake in Avanos Medical by 16.6% in the 4th quarter. Alberta Investment Management Corp now owns 413,418 shares of the company’s stock valued at $9,273,000 after buying an additional 58,826 shares in the last quarter. Kestrel Investment Management Corp acquired a new stake in Avanos Medical in the 4th quarter valued at $3,265,000. BNP Paribas Financial Markets boosted its stake in Avanos Medical by 314.4% in the first quarter. BNP Paribas Financial Markets now owns 53,583 shares of the company’s stock worth $1,067,000 after purchasing an additional 40,653 shares in the last quarter. Norges Bank acquired a new position in Avanos Medical in the fourth quarter worth $7,016,000. Finally, Tributary Capital Management LLC boosted its stake in Avanos Medical by 7.5% in the first quarter. Tributary Capital Management LLC now owns 742,455 shares of the company’s stock worth $14,782,000 after purchasing an additional 51,865 shares in the last quarter. 95.17% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. JMP Securities reissued a “market perform” rating on shares of Avanos Medical in a research note on Tuesday, May 7th. StockNews.com raised Avanos Medical from a “hold” rating to a “buy” rating in a research note on Saturday, May 11th.

Avanos Medical Trading Up 1.1 %

Shares of AVNS stock traded up $0.26 on Friday, reaching $24.01. 434,461 shares of the stock were exchanged, compared to its average volume of 211,085. The stock has a market cap of $1.10 billion, a PE ratio of -18.05 and a beta of 0.94. Avanos Medical, Inc. has a one year low of $17.24 and a one year high of $24.77. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.28 and a quick ratio of 1.47. The stock has a 50 day moving average price of $20.61 and a 200 day moving average price of $19.77.

Avanos Medical (NYSE:AVNS) last released its earnings results on Wednesday, July 31st. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.05. The company had revenue of $171.70 million during the quarter, compared to the consensus estimate of $170.67 million. Avanos Medical had a return on equity of 4.48% and a net margin of 1.13%. The firm’s quarterly revenue was up 1.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.24 earnings per share. Equities research analysts forecast that Avanos Medical, Inc. will post 1.38 EPS for the current fiscal year.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.